152 related articles for article (PubMed ID: 17094482)
1. Constitutive expression of RbAp46 induces epithelial-mesenchymal transition in mammary epithelial cells.
Li GC; Wang ZY
Anticancer Res; 2006; 26(5A):3555-60. PubMed ID: 17094482
[TBL] [Abstract][Full Text] [Related]
2. RbAp46 inhibits estrogen-stimulated progression of neoplastigenic breast epithelial cells.
Zhang TF; Yu SQ; Wang ZY
Anticancer Res; 2007; 27(5A):3205-9. PubMed ID: 17970062
[TBL] [Abstract][Full Text] [Related]
3. Constitutive expression of Rb associated protein 46 (RbAp46) reverts transformed phenotypes of breast cancer cells.
Zhang TF; Yu SQ; Deuel TF; Wang ZY
Anticancer Res; 2003; 23(5A):3735-40. PubMed ID: 14666671
[TBL] [Abstract][Full Text] [Related]
4. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton.
Wicki A; Lehembre F; Wick N; Hantusch B; Kerjaschki D; Christofori G
Cancer Cell; 2006 Apr; 9(4):261-72. PubMed ID: 16616332
[TBL] [Abstract][Full Text] [Related]
5. Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1.
Chen GC; Guan LS; Yu JH; Li GC; Choi Kim HR; Wang ZY
Biochem Biophys Res Commun; 2001 Jun; 284(2):507-14. PubMed ID: 11394910
[TBL] [Abstract][Full Text] [Related]
6. Arachidonic acid promotes epithelial-to-mesenchymal-like transition in mammary epithelial cells MCF10A.
Martinez-Orozco R; Navarro-Tito N; Soto-Guzman A; Castro-Sanchez L; Perez Salazar E
Eur J Cell Biol; 2010 Jun; 89(6):476-88. PubMed ID: 20207443
[TBL] [Abstract][Full Text] [Related]
7. Expression profiling of epithelial plasticity in tumor progression.
Jechlinger M; Grunert S; Tamir IH; Janda E; Lüdemann S; Waerner T; Seither P; Weith A; Beug H; Kraut N
Oncogene; 2003 Oct; 22(46):7155-69. PubMed ID: 14562044
[TBL] [Abstract][Full Text] [Related]
8. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A
Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
Chaffer CL; Brennan JP; Slavin JL; Blick T; Thompson EW; Williams ED
Cancer Res; 2006 Dec; 66(23):11271-8. PubMed ID: 17145872
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer.
Thakur A; Rahman KW; Wu J; Bollig A; Biliran H; Lin X; Nassar H; Grignon DJ; Sarkar FH; Liao JD
Mol Cancer Res; 2007 Feb; 5(2):171-81. PubMed ID: 17314274
[TBL] [Abstract][Full Text] [Related]
11. [Epithelial-mesenchymal transition in cancer progression].
Gos M; Miłoszewska J; Przybyszewska M
Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
[TBL] [Abstract][Full Text] [Related]
12. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
[TBL] [Abstract][Full Text] [Related]
13. Inducible expression of RbAp46 activates c-Jun NH2-terminal kinase-dependent apoptosis and suppresses progressive growth of tumor xenografts in nude mice.
Zhang TF; Yu SQ; Loggie BW; Wang ZY
Anticancer Res; 2003; 23(6C):4621-7. PubMed ID: 14981905
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal and mesenchymal-epithelial transitions during cancer progression.
Spaderna S; Schmalhofer O; Hlubek F; Jung A; Kirchner T; Brabletz T
Verh Dtsch Ges Pathol; 2007; 91():21-8. PubMed ID: 18314592
[TBL] [Abstract][Full Text] [Related]
16. [Expressive profile of retinoblastoma-associated protein 46 and its clinical significance in acute leukemias].
Zhou JC; Zhang GS
Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):86-9. PubMed ID: 15921624
[TBL] [Abstract][Full Text] [Related]
17. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
19. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
[TBL] [Abstract][Full Text] [Related]
20. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
